Vicarious Surgical Stock Alpha and Beta Analysis
| RBOT Stock | USD 2.65 0.21 7.34% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Vicarious Surgical. It also helps investors analyze the systematic and unsystematic risks associated with investing in Vicarious Surgical over a specified time horizon. Remember, high Vicarious Surgical's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Vicarious Surgical's market risk premium analysis include:
Beta 3.51 | Alpha (1.40) | Risk 6.85 | Sharpe Ratio (0.16) | Expected Return (1.09) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Vicarious | Build AI portfolio with Vicarious Stock |
Vicarious Surgical Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Vicarious Surgical market risk premium is the additional return an investor will receive from holding Vicarious Surgical long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Vicarious Surgical. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Vicarious Surgical's performance over market.| α | -1.4 | β | 3.51 |
Vicarious Surgical expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Vicarious Surgical's Buy-and-hold return. Our buy-and-hold chart shows how Vicarious Surgical performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Vicarious Surgical Market Price Analysis
Market price analysis indicators help investors to evaluate how Vicarious Surgical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vicarious Surgical shares will generate the highest return on investment. By understating and applying Vicarious Surgical stock market price indicators, traders can identify Vicarious Surgical position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Price Ceiling Movement | ||
| Tangent Of Price Series | ||
| Aroon Oscillator | ||
| Aroon Oscillator | ||
| Kaufman Adaptive Moving Average | ||
| Bollinger Bands | ||
| Rickshaw Man | ||
| Harami Cross Pattern |
Vicarious Surgical Return and Market Media
The median price of Vicarious Surgical for the period between Mon, Oct 20, 2025 and Sun, Jan 18, 2026 is 2.83 with a coefficient of variation of 39.94. The daily time series for the period is distributed with a sample standard deviation of 1.41, arithmetic mean of 3.53, and mean deviation of 1.23. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | How high can Vicarious Surgical Inc. Equity Warrant stock go - 2025 Price Action Summary AI Based Trade Execution Alerts - newser.com | 11/05/2025 |
2 | Will Vicarious Surgical Inc. stock gain from lower inflation - July 2025 Catalysts Advanced Technical Signal Analysis - newser.com | 11/19/2025 |
3 | Disposition of 2 shares by Sammy Khalifa of Vicarious Surgical at 7.2509 subject to Rule 16b-3 | 11/24/2025 |
4 | Will Vicarious Surgical Inc. Warrants each stock profit from automation wave - Quarterly Portfolio Report Consistent Growth Stock Picks - Newser | 12/04/2025 |
5 | Disposition of 1290 shares by Kelly William John of Vicarious Surgical at 0.3 subject to Rule 16b-3 | 12/05/2025 |
6 | Vicarious Surgical sees FY2026 cash burn of 35 million - MSN | 12/17/2025 |
7 | Vicarious Surgical Announces Strategic Software Execution Partnership to Streamline Operations | 12/29/2025 |
8 | Why Vicarious Surgical Inc. Equity Warrant stock could be next big winner - Earnings Miss Reliable Price Breakout Signals - ulpravda.ru | 01/08/2026 |
9 | Vicarious Surgical Advances Toward Design Freeze with Successful In-Vivo Porcine Lab | 01/12/2026 |
About Vicarious Surgical Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Vicarious or other stocks. Alpha measures the amount that position in Vicarious Surgical has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | PB Ratio | 0.54 | 1.66 | 1.91 | 1.81 | Capex To Depreciation | 0.9 | 0.0854 | 0.0982 | 0.0933 |
Vicarious Surgical Upcoming Company Events
As portrayed in its financial statements, the presentation of Vicarious Surgical's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Vicarious Surgical's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Vicarious Surgical's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Vicarious Surgical. Please utilize our Beneish M Score to check the likelihood of Vicarious Surgical's management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 12th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Vicarious Surgical
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.